Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
Author:
Affiliation:
1. Department of Medicine, Samsung Medical Center; Sungkyunkwan University School of Medicine; Seoul South Korea
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28916/fullpdf
Reference30 articles.
1. KASL clinical practice guidelines: management of chronic hepatitis B;Korean Association for the Study of the Liver;Clin Mol Hepatol,2016
2. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B;Chang;Hepatology,2010
3. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study;Marcellin;Lancet,2013
4. Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B;Singal;Aliment Pharmacol Ther,2013
5. Lamivudine for patients with chronic hepatitis B and advanced liver disease;Liaw;N Engl J Med,2004
Cited by 144 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysis;Frontiers in Gastroenterology;2024-01-24
2. Multiple Low-level Viremia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients during Antiviral Therapy;2024-01-23
3. Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria;Hepatology Communications;2024-01
4. Real‐world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B;Journal of Viral Hepatitis;2024-01
5. Antiviral Therapy of Chronic Hepatitis D Virus Infection – Addendum to the S3 Guideline “Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection” of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS);Zeitschrift für Gastroenterologie;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3